Osteoarthritis, also known as degenerative arthritis or degenerative joint disease, is a group of mechanical abnormalities involving degradation of joints, including articular cartilage and subchondral bone.

Symptoms may include joint pain, tenderness, stiffness, locking, and sometimes an effusion. When bone surfaces become less well protected by cartilage, bone may be exposed and damaged.

As a result of decreased movement secondary to pain, regional muscles may atrophy, and ligaments may become more lax.

Stem cell therapy has been demonstrated to induce profound healing activity in animals with various forms of arthritis.

For example, the company Vet-Stem routinely utilizes stem cells in horses with various joint deformities to accelerate healing.

Besides healing of damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving ability to fight off disease.

The adult stem cells used to treat osteoarthritis come from human umbilical cord tissue (allogeneic mesenchymal).

The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.

All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.

Only a small percentage of donated umbilical cords pass our rigorous screening process.

For many years we have led the industry in technical innovation by partnering many experts and dedicate to being at the cutting edge that allows us to provide the best stem cell care.

Partnering with many international-renowned experts in stem cell transplantation, We are guided by the Foundation for the Accreditation of Cellular Therapy (FACT), the Medical Council, and a set of international medical ethics in research and development for stem cell transplantation.

Because of our high proficiency in research, we have advanced stem cell technology through clinical trials and are rapidly moving our most advanced developments to clinical practice. Our team of qualified medical experts work to ensure an international standard of care.